NCT00062296: Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia |
|
|
| Completed | 2 | 5 | US | rituximab, epirubicin hydrochloride | Fox Chase Cancer Center, National Cancer Institute (NCI) | Leukemia, Lymphoma | 08/05 | 08/05 | | |
NCT00556127: Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma |
|
|
| Completed | 2 | 94 | Europe | Rituximab, Epirubicin, Cyclophosphamide, Vincristine, Prednisone, Granulocyte-colony-stimulating factor, Mitoxantrone, Cytarabine ARA-C, Dexamethasone, Carmustine BCNU, Etoposide, Melphalan, Radiotherapy, PBSC reinfusion | Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie | Diffuse Large B-Cell Lymphoma, POOR PROGNOSIS | | 09/06 | | |
